Literature DB >> 19023658

Longitudinal effects of LAAM and methadone maintenance on heroin addict behavior.

M Douglas Anglin1, Bradley T Conner, Jeffrey J Annon, Douglas Longshore.   

Abstract

Levo-alpha-acetylmethadol maintenance (LAAM) was compared to methadone maintenance (MM) on the behavioral performance of 315 heroin addicts before, during, and after 12 months of fully subsidized treatment. Assessments of drug use, criminal behavior, HIV risk behaviors, and employment and residential status were obtained at treatment intake and at 6, 12, and 18 months after admission. Treatment retention and in-treatment suppression of heroin use were significantly better for the LAAM group than for the MM group. Improvements were also noted during treatment in criminal behavior, criminal justice involvement, and employment status, and there were reductions in injection HIV risk and number of sexual partners. Most significant effects were primarily related to active participation in maintenance treatment. Under subsidized treatment, retention rates were two to four times that of similar clients in local community programs during the same period. LAAM was a useful and a potentially important addition to treatment options for opiate addiction, conferring greater retention and opiate suppression benefits. Its removal from application provides a historical lesson concerning the introduction of new medications into addiction health services.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19023658     DOI: 10.1007/s11414-008-9155-x

Source DB:  PubMed          Journal:  J Behav Health Serv Res        ISSN: 1094-3412            Impact factor:   1.505


  18 in total

1.  Conversation with M. Douglas Anglin.

Authors:  M Douglas Anglin
Journal:  Addiction       Date:  2006-02       Impact factor: 6.526

2.  Years of potential life lost among heroin addicts 33 years after treatment.

Authors:  Breda Smyth; Valerie Hoffman; Jing Fan; Yih-Ing Hser
Journal:  Prev Med       Date:  2007-02-08       Impact factor: 4.018

3.  Can LAAM, like Lazarus, come back from the dead?

Authors:  Jerome H Jaffe
Journal:  Addiction       Date:  2007-09       Impact factor: 6.526

4.  Drug use and crime: a historical review of research conducted by the UCLA Drug Abuse Research Center.

Authors:  M D Anglin; B Perrochet
Journal:  Subst Use Misuse       Date:  1998-07       Impact factor: 2.164

5.  What happens when a demonstration project ends. Consequences for a clinic and its clients.

Authors:  C E Grella; M D Anglin; R Rawson; R Crowley; A Hasson
Journal:  J Subst Abuse Treat       Date:  1996 May-Jun

6.  HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone.

Authors:  David C Lott; Eric C Strain; Robert K Brooner; George E Bigelow; Rolley E Johnson
Journal:  J Subst Abuse Treat       Date:  2006-07-18

7.  Reducing HIV risk behavior among injection drug users: effect of methadone maintenance treatment on number of sex partners.

Authors:  D Longshore; S C Hsieh; M D Anglin
Journal:  Int J Addict       Date:  1994-04

Review 8.  Medication development for addictive disorders: the state of the science.

Authors:  Frank J Vocci; Jane Acri; Ahmed Elkashef
Journal:  Am J Psychiatry       Date:  2005-08       Impact factor: 18.112

Review 9.  Eyes wide shut?--A conceptual and empirical critique of methadone maintenance treatment.

Authors:  Benedikt Fischer; Jürgen Rehm; Gregory Kim; Maritt Kirst
Journal:  Eur Addict Res       Date:  2005       Impact factor: 3.015

10.  Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis.

Authors:  David A L Newcombe; Felix Bochner; Jason M White; Andrew A Somogyi
Journal:  Drug Alcohol Depend       Date:  2004-10-05       Impact factor: 4.492

View more
  2 in total

1.  Introduction to the special issue on addiction health services: in memory of Douglas Longshore.

Authors:  Christine E Grella; M Douglas Anglin
Journal:  J Behav Health Serv Res       Date:  2008-12-10       Impact factor: 1.505

Review 2.  Advances in the delivery of buprenorphine for opioid dependence.

Authors:  Richard N Rosenthal; Viral V Goradia
Journal:  Drug Des Devel Ther       Date:  2017-08-28       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.